Amy Abernethy

The U.S. Senate confirmation of Robert Califf, MD, as FDA Commissioner was hailed by his colleagues in the world of clinical research and academic medicine.

February 15, 2022

Announcements In the News

LeBlanc And Abernethy Patient-Care Paper Recognized

A journal article by hematologic oncologist, palliative care physician, and associate professor of medicine Thomas LeBlanc, MD, and adjunct professor ...

June 4, 2018

Announcements Awards DCI Research

April Newsmakers

Two Faculty Elected to American Academy of Arts and Sciences (Duke Today) A New Way of Looking at Melanomas and Renaissance Paintings (Duke T...

May 12, 2015

In the News

Pain Management Via Skype Could Be Just What The Doctor Ordered

Preliminary results of a four-year study led by Duke Cancer Institute clinical psychologist Tamara Somers, PhD, appear to conclude that, when delivere...

August 16, 2018

DCI Research Features

Kamal, Abernethy Co-Author Cover Story for Oncology Issues

The DCI's Arif Kamal, MD, and Amy Abernethy, MD, are among the authors of the cover story of the May-June issue of Oncology Issues. Their article deta...

May 12, 2015

In the News DCI Research

December Newsmakers

FDA Names Flatiron Health Executive Amy Abernethy Deputy Commissioner (Forbes) Features DCI alum Amy Abernethy, MD Older Americans Are Flocking to...

December 5, 2018

In the News

May Newsmakers

As doctors work to solve eye cancer mystery, Huntersville family remembers daughters' spirit (WRAL.com) Features Miguel Materin, MD Many cancer pa...

April 26, 2018

In the News DCI Research